BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27069015)

  • 1. Synovial fluid mononuclear cells provide an environment for long-term survival of antibody-secreting cells and promote the spontaneous production of anti-citrullinated protein antibodies.
    Kerkman PF; Kempers AC; van der Voort EI; van Oosterhout M; Huizinga TW; Toes RE; Scherer HU
    Ann Rheum Dis; 2016 Dec; 75(12):2201-2207. PubMed ID: 27069015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD95-Mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints.
    Rodríguez-Bayona B; Pérez-Venegas JJ; Rodríguez C; Brieva JA
    Rheumatology (Oxford); 2007 Apr; 46(4):612-6. PubMed ID: 17132692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission.
    Pelzek AJ; Grönwall C; Rosenthal P; Greenberg JD; McGeachy M; Moreland L; Rigby WFC; Silverman GJ
    Arthritis Rheumatol; 2017 Jun; 69(6):1176-1186. PubMed ID: 28118534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.
    Rombouts Y; Willemze A; van Beers JJ; Shi J; Kerkman PF; van Toorn L; Janssen GM; Zaldumbide A; Hoeben RC; Pruijn GJ; Deelder AM; Wolbink G; Rispens T; van Veelen PA; Huizinga TW; Wuhrer M; Trouw LA; Scherer HU; Toes RE
    Ann Rheum Dis; 2016 Mar; 75(3):578-85. PubMed ID: 25587188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis.
    Kerkman PF; Rombouts Y; van der Voort EI; Trouw LA; Huizinga TW; Toes RE; Scherer HU
    Ann Rheum Dis; 2013 Jul; 72(7):1259-63. PubMed ID: 23625975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid.
    Scherer HU; van der Woude D; Ioan-Facsinay A; el Bannoudi H; Trouw LA; Wang J; Häupl T; Burmester GR; Deelder AM; Huizinga TW; Wuhrer M; Toes RE
    Arthritis Rheum; 2010 Jun; 62(6):1620-9. PubMed ID: 20178128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
    Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
    Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
    Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
    Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients.
    Reparon-Schuijt CC; van Esch WJ; van Kooten C; Levarht EW; Breedveld FC; Verweij CL
    Arthritis Rheum; 1998 Dec; 41(12):2211-20. PubMed ID: 9870878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the ability of anti-cyclic citrullinated peptide antibodies determination in synovial fluid in discriminating rheumatoid arthritis from non-rheumatoid arthritis patients? A Tunisian cross-sectional study.
    Mrabet D; Laadhar L; Sahli H; Zouari B; Haouet S; Lahmar H; Makni S; Sellami S
    Clin Rheumatol; 2012 Feb; 31(2):375-9. PubMed ID: 21952975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations.
    Willemze A; Shi J; Mulder M; Stoeken-Rijsbergen G; Drijfhout JW; Huizinga TW; Trouw LA; Toes RE
    Ann Rheum Dis; 2013 Jun; 72(6):1059-63. PubMed ID: 23486413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.
    Lundström SL; Fernandes-Cerqueira C; Ytterberg AJ; Ossipova E; Hensvold AH; Jakobsson PJ; Malmström V; Catrina AI; Klareskog L; Lundberg K; Zubarev RA
    PLoS One; 2014; 9(11):e113924. PubMed ID: 25426976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis.
    Kerkman PF; Fabre E; van der Voort EI; Zaldumbide A; Rombouts Y; Rispens T; Wolbink G; Hoeben RC; Spits H; Baeten DL; Huizinga TW; Toes RE; Scherer HU
    Ann Rheum Dis; 2016 Jun; 75(6):1170-6. PubMed ID: 26034045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
    Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis.
    Schuerwegh AJ; Ioan-Facsinay A; Dorjée AL; Roos J; Bajema IM; van der Voort EI; Huizinga TW; Toes RE
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2586-91. PubMed ID: 20133791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis.
    Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
    Clin Exp Rheumatol; 2007; 25(4):599-604. PubMed ID: 17888217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
    Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
    J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D
    Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.